Home › Funds › Soleus Capital Management, L.P. › NVCT

Soleus Capital Management, L.P. position in NVCT

NUVECTIS PHARMA INC · Health Care

Soleus Capital Management, L.P. reported holding 1,710,658 shares of NVCT (NUVECTIS PHARMA INC) in its Q3 2026 13F filing — a position valued at US$36.1M, representing 1.28% of its reported portfolio and ranking #22 among its reported holdings. Soleus Capital Management, L.P. has disclosed NVCT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.71M sh
Reported value held$36.13M
Portfolio Weight1.28%
First reportedQ2 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Soleus Capital Management, L.P.'s NVCT position evolved

Soleus Capital Management, L.P. first disclosed a stake in NVCT in Q2 2026 at 1,000,000 shares (US$18.4M). The position peaked in Q3 2026 at 1,710,658 shares, worth US$36.1M. Across 2 filings, Soleus Capital Management, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,710,658 shares valued at US$36.1M — an increase of 710,658 shares quarter over quarter.. Notable position changes include a 71% increase in Q3 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.00M $18.39M New
Q3 2026 1.71M $36.13M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVCT and 13F data

NVCT (NUVECTIS PHARMA INC) is a Health Care company. 62 other funds we track also report a position in NVCT — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$33.3M), BRAIDWELL LP (US$33.2M), IRIDIAN ASSET MANAGEMENT LLC/CT (US$16.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVCT

All NVCT fund holders →

FAQ

How long has Soleus Capital Management, L.P. held NVCT?

Soleus Capital Management, L.P. has disclosed NVCT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Soleus Capital Management, L.P.'s current position in NVCT?

As of Q3 2026, Soleus Capital Management, L.P. holds 1.71M shares of NVCT (NUVECTIS PHARMA INC), valued at $36.13M, representing 1.28% of its reported portfolio and ranking #22.

Has Soleus Capital Management, L.P. been buying or selling NVCT?

In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. increased its position in NVCT. The position peaked in Q3 2026 at 1.71M shares.

Which other funds hold NVCT?

Other major institutional holders of NVCT include TANG CAPITAL MANAGEMENT LLC, BRAIDWELL LP, IRIDIAN ASSET MANAGEMENT LLC/CT, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.